Personalized Medicine in lung Cancer

The era of personalized treatment for lung cancer will involve a comprehensive genomic characterization of adenocarcinoma, squamous-cell carcinoma, and small-cell carcinoma into various subtypes. Precision medicine is to develop treatments that exploit weak spots in tumor cells to destroy only the cancer cells (as compared to traditional chemotherapy and radiation). Weak spots have been found in two genes, EGFR and ALK, both found in adenocarcinoma NSCLC.

  • Lung cancer surgery
  • Management of Chemotherpay
  • Non-smallcell lung cancer
  • Pathogenesis
  • Lung cancer clinical trials and research

Related Conference of Personalized Medicine in lung Cancer

June 21-22, 2017

3rd International Conference on Cytopathology & Histopathology

Philadelphia, Pennsylvania, USA
June 26-27, 2017

8th World Congress on Molecular Pathology

San Diego,California,USA
August 02-03, 2017

13th European Pathology Congress

Milan, Italy
August 23-24, 2017

4th World Congress on Breast Pathology and Cancer Diagnosis

Toronto, Canada [Holiday Inn Toronto International Airport]
Sep 11-12, 2017

World Annual Pathologists Congress

Los Angeles, USA
November 13-14, 2017

14th Asia Pacific Pathology Congress

Osaka, Japan
November 15-16, 2017

2nd International Conference on Digital Pathology

San Antonio, USA

Personalized Medicine in lung Cancer Conference Speakers

Recommended Sessions

Related Journals

Are you interested in